"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 21 | 21 |
| 2004 | 0 | 69 | 69 |
| 2005 | 0 | 69 | 69 |
| 2006 | 1 | 62 | 63 |
| 2007 | 0 | 71 | 71 |
| 2008 | 1 | 83 | 84 |
| 2009 | 2 | 114 | 116 |
| 2010 | 0 | 98 | 98 |
| 2011 | 1 | 121 | 122 |
| 2012 | 2 | 99 | 101 |
| 2013 | 2 | 117 | 119 |
| 2014 | 0 | 146 | 146 |
| 2015 | 0 | 144 | 144 |
| 2016 | 0 | 159 | 159 |
| 2017 | 0 | 122 | 122 |
| 2018 | 0 | 148 | 148 |
| 2019 | 1 | 133 | 134 |
| 2020 | 0 | 124 | 124 |
| 2021 | 0 | 112 | 112 |
| 2022 | 0 | 44 | 44 |
| 2023 | 0 | 54 | 54 |
| 2024 | 0 | 102 | 102 |
| 2025 | 0 | 84 | 84 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength. Cancer Immunol Res. 2025 Oct 01; 13(10):1576-1590.
-
Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas. Cancer Immunol Res. 2025 Oct 01; 13(10):1591-1608.
-
Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2025 Oct 01; 31(19):4184-4195.
-
Synthesis, Structure-Activity Relationships, and Antitumor Activities of Quinoxiline-Containing Inhibitors of the Protein-Protein Interactions between Transcription Coactivator AF9/ENL and DOT1L/AF4. J Med Chem. 2025 Sep 25; 68(18):19396-19414.
-
Central memory-enriched V?9Vd2 ?d T cells via TGF-? expansion demonstrate enhanced in vivo efficacy against metastatic osteosarcoma. Front Immunol. 2025; 16:1657760.
-
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. Clin Cancer Res. 2025 Sep 02; 31(17):3754-3770.
-
Comparison of the Cytotoxicity, Internalization and Anti-Cancer Drug Delivery Efficacy of Nature Killer Cell Derived Nanovesicles and Extracellular Vesicles. Int J Nanomedicine. 2025; 20:10683-10700.
-
Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy. Cell Rep Med. 2025 Sep 16; 6(9):102324.
-
Divergent Roles of C/EBP? Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple-Negative Breast Cancer. FASEB J. 2025 Aug 31; 39(16):e70984.
-
Rational Design of PEGylated Nanogels: Optimization of Degree of PEGylation and Development of a Novel Enzyme-Responsive Grafted Layer. Int J Pharm. 2025 Nov 10; 684:126102.